MRNA
MRNA Moderna vaccine 94.5% effective in Phase 3 trial!This was my previews post about Moderna:
The indicators are still bullish. The price of the stock grew 5X since the beginning of the year.
11/16/2020 Oppenheimer Boost Price Target ➝ $157.00
11/16/2020 Piper Sandler Boost Price Target ➝ $166.00
The traditional method of creating vaccines – introducing a weakened or dead virus, or a piece of one, to stimulate the body's immune system – takes over a decade on average, according to a 2013 study. One pandemic flu vaccine took over eight years while a hepatitis B vaccine was nearly 18 years in the making.
Moderna's vaccine went from gene sequencing to the first human injection in 63 days.
Moderna and BioNTech, for example, are also applying mRNA technology to experimental cancer medicines.
BioNTech's vaccine, for example, must be transported at minus 70 degrees Celsius, though Moderna said on Monday it can ship its candidate in normal refrigerators. (Reuters)
If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
MRNA , MODERNA INC ..its time to sale!! it gonna see a big downturn today !!
and its really difficult to climb back up again ..
don't miss the change today .
MRNA breaking out on vaccines breakthrough.Moderna says its vaccine is 94.5% effective in preventing COVID-19
Reuters
Moderna says its vaccine is 94.5% effective in preventing COVID-19
Julie Steenhuysen and Michael Erman
Mon, November 16, 2020, 7:58 PM GMT+8
By Julie Steenhuysen and Michael Erman
Nov 16 (Reuters) - Moderna Inc said on Monday its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second U.S. company in a week to report results that far exceed expectations.
Together with Pfizer Inc's vaccine, also shown to be more than 90% effective, and pending more safety data and regulatory review, the United States could have two vaccines authorized for emergency use in December with as many as 60 million doses of vaccine available by the year's end.
Next year, the U.S. government could have access to more than 1 billion doses just from the two vaccine makers, more than needed for the country's 330 million residents.
The vaccines, both built using new technology known as messenger RNA or mRNA, represent powerful new tools to fight a pandemic that has infected 54 million people worldwide and killed 1.3 million. The news also comes at time when COVID-19 cases are soaring, hitting new records in the United States and pushing some European countries back into lockdowns.
"We are going to have a vaccine that can stop COVID-19," Moderna President Stephen Hoge said in a telephone interview.
Moderna's interim analysis was based on 95 infections among trial participants who received either a placebo or the vaccine. Of those, only five infections occurred in those who received the vaccine, which is administered in two shots 28 days apart.
A key advantage of Moderna's vaccine is that it does not need ultra-cold storage like Pfizer's, making it easier to distribute. Moderna expects it to be stable at standard refrigerator temperatures of 2 to 8 degrees Celsius (36 to 48°F) for 30 days and it can be stored for up to 6 months at -20 degrees Celsius.
Stocks To Watch This Week Nov 14I went through and created a watchlist for names that have held up well in this choppy environment. Most of these names are at or near all time highs or multi year highs. There are 40 total stocks on this list. Many of these have IPO'd in the last few years and still have a growth story ahead of them. There are also some financial stocks which may be starting to outperform the broader market. Know your time frame and risk tolerance, grab a pencil and paper and jot down the names that look interesting to you and then make the trade your own. Good Luck!
TT Blackbox $MRNA Bearish Swing TradeGreen Line - Entry Target
Red Line - Exit Target
Pink Line - Stop-Loss
Highly suggest using Google to Search "Transparent Traders" if you're trying to get to the next level.
Transparent Traders exists to solve the critical issues facing our traders, both large and small. Our unique approach is not only what differentiates us, but also what makes us successful.
Our advanced Blackbox uses custom algorithms & predictive A.I. to locate the most accurate day or swing trades for the best chance of success.
Moderna Stock Analysis - MRNAPrices are moving inside the channel - the best option would be to hold.
It is too risky to go long now, but it seems that the probabilities that the price will go up are higher than it will go down.
MRNA Moderna Cup and Handleplenty of news coming up for this name. has all the catalysts coming, phase 3 results, filing for emergency approval and emergency approval itself. just needs the volume to go higher and retest ATH maybe in December
MRNA 8H: BEST Level to BUY/HOLD 80% gains(SL/TP)(STOCKS)Why get subbed to me on Tradingview?
-TOP author on TradingView
-15+ years experience in markets
-Professional chart break downs
-Supply/Demand Zones
-TD9 counts / combo review
-Key S/R levels
-No junk on my charts
-Frequent updates
-Covering FX/crypto/US stocks
-24/7 uptime so constant updates
MRNA 8H: BEST Level to BUY/HOLD 80% gains(SL/TP)(STOCKS)
IMPORTANT NOTE: speculative setup. do your own
due dill. use STOP LOSS. don't overleverage.
🔸 Summary and potential trade setup
::: MRNA 8hour chart review and outlook
::: Biotech sector outperforming market
::: Currenly in accumulation stage
::: Buying low near range lows
::: is the best strategy BULLS
::: wait for pullback/dips and BUY IT
::: recommended strategy: BUY LOW 55 USD
::: SL 45 US TP is 95/100 USD +80%/+100% gains
::: BUY/HOLD setup
::: DO NOT expect overnight gains
::: This is stock market
::: Not casino in Macau
🔸 Supply/Demand Zones
. N/A
🔸 Why should I follow your setups?
:::Check track record it's all been posted
::: MRNA 200%+ gains, NVAX 300% gains, REG 60%
::: AMD 40% gains and a lot more in 2020
LONG $DGX ER run up ($MRNA $GILD $INO $SPY)see charts at www.tradingview.com
$DGX Entry 120
Target 1 $125
Target 2 $130
Why DGX?
FDA Authorizes Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit for Emergency Use
With Covid wave 2 on the rise, this could be a huge player.
www.prnewswire.com
What is DGX?
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, United Kingdom, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
MRNA Bullish weekMRNA is again entering in the trend line, I think the price will continue to go up in the next couple of days.
WDYT?
Long Gild - Covid Drug ($MRNA $GSK $INO $SPY $PFE $JNJ $MRK)see full chart at www.tradingview.com
Gild
Entry $62 area
Target 1 $67
Target 2 $71
stoploss $59
Why this play?
Trump used Gild's drug as part of his treatment, if he pulls thru with a full recovery. they will probably start pumping the news about this company and it'll finally have enough momentum to move back to the upside.
What is Gild?
Gilead Sciences, Inc., is an American biopharmaceutical company headquartered in Foster City, California that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
Notable price upgrades
Sep-30-20 Resumed Jefferies Buy $78
Sep-15-20 Upgrade Maxim Group Hold → Buy $88
My two cents on my most profitable traded stock this year, MRNAI have traded MRNA more than any other stock. Even if you lack the experience and know-how of trading, following some basics trends will give you a high winning percentage with this stock.
1) Finding the premarket high and shorting the stock close to that gives you about an 85% chance of a 50cent-$1 move before market opens.
2) A lot of the news on this stock is old and reused. Today for example there is news that seniors exhibit very few health issues with the stock. This is old news.
3) With every single run up including the first major one close to $100 a few months back, MRNA has flushed 100% of the time with no ability to maintain the premarket levels.
I had a lame effort a liitle while ago but the media is bad Media is scattered and the good news run ups have been bad. Still the tech is great and will see what happens
MRNA HOLD BULLISHI am not swinging this one, even though it is tempting.
I recently sold NVAX at 15% profit, and due to strong correlation with MRNA I was considering selling my MRNA as well, in which case I would have made 14% right now.
However, I decided to hold because of 2 reasons :
1) AstraZeneca just took a major hit (if you don't know about it, catch up on the news). This takes out a bit of competition and investor fund distribution might come this way
2) MRNA shows a strong uptrend with good momentum, and that is mainly why I will HOLD it for longer term.
Hit like if you found this helpful and interesting.
Thanks, E
MRNA - THE CEO THAT SOLD - SHARE YOUR FEEDBACKPLEASE READ THE ENTIRE POST, IT MIGHT JUST SAVE YOU A SOUR INVESTMENT
I have been following MRNA for about a month now, and something interesting has happened that not many people know about.
On 4 September, news came out that the CMO, the President AND the CEO have sold large if not all of their holdings.*
Now the company says that this is no reason to panic. (sounds like what we were told about corona in December...)
On the trading platform I use, I have also gotten a notification about insiders selling. This is a built in strategy used along with others to determine the market consensus of the stock (buy, strong buy, hold etc)
We can all probably agree that when head management sell most of their holdings, and not 1 person but 3 senior members, it is generally not a good sign.
Now here is where I'd like your feedback - The large selling off their stocks hasn't been reflecting in the market. In fact, MRNA has been on one long bull run with minor short term bearish chart patterns.
Why would it be that the sell off doesn't reflect in the market?
I personally sold my stock immediately after I saw a report on this from Gurufinder, later confirmed by more mainstream news and other platforms. My opinion is that The company has to portray that they believe their stocks are going all the way up which in this case, selling off massive holdings at the peak tells me that they are taking their profit. Compare this to PFE (Pfizer), whos director INCREASED his holdings. Now that speaks of confidence in the company, right?
* INFO FROM MY TRADING PLATFORM
CEO, SOLD $1,293,810, DATE 18.09.20
PRESIDENT, SOLD $1,228,468, DATE 15.09.20
CMO, SOLD $1,255,321, DATE 15.09.20
Please share your constructive and respectful feedback, and thank you !
Hit like if you found this interesting,
Ev
MRNA: Timeline of Clinical Trials; Operation Warp SpeedThis is a timeline of funding related to the US Government's Operation Warp Speed. MRNA and NVAX are the two stocks that have reacted strongly (in both directions) to any kind of COVID news. You can see that towards the end of phase 1 trials, they disclosed grade 3 adverse reactions to the vaccine which led to a -50% drop in the stock.
Is MRNA revealing major upside opportunity? BULL or BEAR? Today we're looking at MRNA aka Moderna, the darling biotech that might be the savior of us all should they produce an mRNA vaccine that could be more easily produced and distributed at scale than a traditional vaccine candidate.
Reading into this story I've been intrigued, especially with the nice patterns forming in this chart with an easy to identify Impulse wave and a correction pattern currently forming. Unfortunately, this is always the riskier proposition and we must consider our Bull and Bear cases objectively so that we have a plan.
As you'll see, we recently bounced off the 0.5 fib retracement from the all-time high of $95 all the way back to $53. Looks like a healthy bounce off that level. But we should almost always expect it. There is nothing to get excited about until we see a more convincing bounce with volume.
While I love the long term pattern being set up in this chart with that hopeful bull target of $136.99, there's a lot of work to make up and resistance to overcome before we get anywhere close. The declining volume is something to watch out for. If you zoom in you'll see the upward channel off the bounce paired with the declining volume. This would indicate that short term we'll retest the low, and if we're lucky we can get a buying opportunity off that low and off the 0.618 at $43.50.
Set your ladders appropriately and always calculate your stop loss according to risk preference fo % loss below average calculated cost. If you plan your buy levels and amount in advance you can easily calculate the average buy price and then subtract 20% for example to reach a reasonable stop loss which shields you from setting a stop loss too high and missing the following run, or setting it too low and losing more than you are willing to.
Meanwhile, looking at the long term trend, we'll have some trading potential on the stock, but need to look for some volatility within the current correction pattern. Given the sharp increase and resulting decrease, one can assume we might see similar moves again in the future, though there's nothing to indicate exactly when at the moment until we see a better channel or a convincing wedge reveal itself.
The longer-term trend bodes well for your everyday investor who's willing to take some loss for a very large potential gain. Should Moderna create their mRNA based vaccine in time and be successful with distribution, the value of this company would quickly skyrocket. I'm willing to bet on an optimistic future and I'm definitely keeping an eye on this opportunity with the buy ladders I've mentioned indicated.
What's your Bull and Bear case on Moderna? How would you play this in the short and long term?
